a year ago
CABA
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Bottom 1%
#4902 out of 4937 analysts
Average Return
-18.35%
Win Rate
28%11 out of 39
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Morphic Holding IncMORF | +109.75% | $27.17 | $56.99 | 2023-12-08 - 2024-08-16 | Strong Buy |
Larimar Therapeutics IncLRMR | +103.34% | $3.29 | $6.69 | 2023-11-17 - 2024-11-15 | Strong Buy |
Immunovant IncIMVT | +78.11% | $16.17 | $28.80 | 2023-04-25 - 2024-04-24 | Strong Buy |
Argenx SeARGX | +40.99% | $435.92 | $614.59 | 2023-11-29 - 2024-11-27 | Strong Buy |
Immunovant IncIMVT | +30.00% | $22.47 | $29.21 | 2023-08-11 - 2024-08-09 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
a year ago
EDIT
a year ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prime Medicine IncPRME | 3 | Hold | $1.50 | -65.52% | Downgrades | 2 months ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $13.00 | +647.13% | Maintains | 2 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $4.00 | +212.50% | Maintains | 2 months ago |
Argenx SeARGX | 6 | Strong Buy | $803.00 | +43.33% | Maintains | 2 months ago |
Structure Therapeutics IncGPCR | 1 | Strong Buy | $60.00 | +215.62% | Initiates Coverage On | 2 months ago |
Bioage Labs IncBIOA | 3 | Hold | $5.00 | +9.65% | Maintains | 4 months ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | +32.16% | Maintains | 6 months ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | +243.84% | Initiates Coverage On | 7 months ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Strong Buy | $31.00 | +42.14% | Maintains | a year ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | +258.85% | Maintains | a year ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $80.00 | N/A | Reinstates | a year ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Strong Buy | $72.00 | N/A | Initiates Coverage On | 2 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 3 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $56.00 | N/A | Maintains | 2 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 2 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.